BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35036508)

  • 1. Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation.
    Jamora KE; Patricia A Cañal J
    Gynecol Oncol Rep; 2022 Feb; 39():100919. PubMed ID: 35036508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Lee SP; Tseng CJ; Hsueh S
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1284-90. PubMed ID: 12128131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic side wall recurrence in locally advanced cervical carcinoma treated with definitive chemoradiation-clinical impact of pelvic wall dose.
    Gangopadhyay A; Saha S
    Br J Radiol; 2019 Dec; 92(1104):20180841. PubMed ID: 31322915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
    Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer.
    van den Akker MJE; Horeweg N; Beltman JJ; Creutzberg CL; Nout RA
    Int J Gynecol Cancer; 2020 Dec; 30(12):1878-1886. PubMed ID: 32591371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
    Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY
    Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
    Lin AJ; Ma S; Markovina S; Schwarz J; Mutch DG; Powell MA; Grigsby PW
    Gynecol Oncol; 2019 Jun; 153(3):530-534. PubMed ID: 30905434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
    Choi KH; Kim JY; Lee DS; Lee YH; Lee SW; Sung S; Park HH; Yoon SC; Hur SY; Park JS; Kim YS
    Medicine (Baltimore); 2018 Apr; 97(16):e0517. PubMed ID: 29668638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
    Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography.
    Rajasooriyar C; Van Dyk S; Lindawati M; Bernshaw D; Kondalsamy-Chennakesavan S; Narayan K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1532-7. PubMed ID: 23027037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.
    Xia X; Xu H; Wang Z; Liu R; Hu T; Li S
    Am J Clin Oncol; 2016 Dec; 39(6):604-608. PubMed ID: 24937635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
    Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
    Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life.
    Akbaba S; Oelmann-Avendano JT; Bostel T; Rief H; Nicolay NH; Debus J; Lindel K; Foerster R
    Radiol Oncol; 2018 Sep; 52(3):320-328. PubMed ID: 30210042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial.
    Curtin JP; Hoskins WJ; Venkatraman ES; Almadrones L; Podratz KC; Long H; Teneriello M; Averette HA; Sevin BU
    Gynecol Oncol; 1996 Apr; 61(1):3-10. PubMed ID: 8626113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
    Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
    J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.